SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001591986-20-000011
Filing Date
2020-07-22
Accepted
2020-07-22 18:15:47
Documents
1
Period of Report
2020-07-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3959
  Complete submission text file 0001591986-20-000011.txt   5811
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address ONE LETTERMAN DRIVE SUITE D4900, BUILDING D SAN FRANCISCO CA 94129
Business Address ONE LETTERMAN DRIVE SUITE D4900, BUILDING D SAN FRANCISCO CA 94129 415-635-0140
Aquilo Capital Management, LLC (Reporting) CIK: 0001591986 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 201042279